Jan Skvarka - 31 Jan 2025 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
Issuer symbol
ZNTL
Transactions as of
31 Jan 2025
Net transactions value
+$103,446
Form type
4
Filing time
04 Feb 2025, 16:45:00 UTC
Previous filing
21 Jun 2024
Next filing
16 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Purchase $103,446 +60,000 +67% $1.72 149,551 31 Jan 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.